JNJ-10198409 3-氟-N-(6,7-二甲氧基-2,4-二氢茚并[1,2-C〕吡唑-3-基)苯基胺
CAS 627518-40-5 MFCD27518405
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, J, Johnson & Johnson, Kinase/Phosphatase Biology, Platelet Derived Growth Factor Receptor (PDGFR), Receptor Tyrosine Kinase Biology, Receptor Tyrosine Kinase Inhibitors, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, J, Johnson & Johnson, Kinase/Phosphatase Biology, Platelet Derived Growth Factor Receptor (PDGFR), Receptor Tyrosine Kinase Biology, Receptor Tyrosine Kinase Inhibitors
相关文献及参考
- Ho, C.Y., et al., (6,7-Dimethoxy-2,4-dihydroindeno[1,2-c]pyrazol-3-yl)phenylamines: platelet-derived growth factor receptor tyrosine kinase inhibitors with broad antiproliferative activity against tumor cells J. Med. Chem. 48 , 8163-8173, (2005) 摘要
- D'Andrea, M.R., et al. , Validation of in vivo pharmacodynamic activity of a novel PDGF receptor tyrosine kinase inhibitor using immunohistochemistry and quantitative image analysis Mol. Cancer Ther. 4 , 1198-1204, (2005) 摘要